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Summary 
For patients with cancer, sleep disturbance is commonplace. Using classical test theory and 
Rasch analyses, the present study compared two commonly used psychometric instruments 
for insomnia – Athens Insomnia Scale (AIS) and Insomnia Severity Index (ISI) – among 
patients with advanced cancer. Through convenience sampling, patients with cancer at stage 
III or IV (n=573; 326 males; mean age=61.3 years; SD=10.7) from eight oncology units of 
university hospitals in Iran participated in the study. All the participants completed the AIS, 
ISI, Edmonton Symptom Assessment Scale (ESAS), Hospital Anxiety and Depression Scale 
(HADS), General Health Questionnaire-12 (GHQ-12), Epworth Sleepiness Scale (ESS), and 
Pittsburgh Sleep Quality Index (PSQI). Additionally, 433 participants wore an Actigraph 
device for two continuous weekdays. Classical test theory and Rasch analysis both supported 
the construct validity for AIS (factor loadings from confirmatory factor analysis [CFA] = 0.61 
to 0.87; test-retest reliability = 0.72 to 0.82; infit mean square [MnSq] = 0.81 to 1.17; outfit 
MnSq = 0.79 to 1.14) and for ISI (factor loadings from CFA = 0.61 to 0.81; test-retest 
reliability = 0.72 to 0.82; infit MnSq = 0.72 to 1.14; outfit MnSq = 0.76 to 1.11). Both AIS 
and ISI had significant associations with ESAS, HADS, GHQ-12, ESS, and PSQI, as well as 
having good sensitivity and specificity. Significant differences in the actigraphy measure 
were found between insomniacs and non-insomniacs based on AIS or ISI score. With 
promising results, healthcare providers can use either AIS or ISI to understand the insomnia 
of patients with advanced cancer. 
Keywords: confirmatory factor analysis; insomnia; sleep disorders; oncology; psychometrics; 
Rasch 
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Introduction 
 For patients with cancer, sleep disturbance is a common occurrence particularly among 
those with breast cancer, lung cancer, head and neck cancer, and gynecologic cancer 
(Langford et al., 2012). In previous studies, the prevalence of disturbed sleep in patients with 
cancer has varied between 30% (Miaskowski et al., 2011) to 93.1% (Lin et al., 2013), which 
is higher than the 9% (Bastien et al., 2001) to 33% (Ohayon & Roth, 2003) found in the 
general population.  
 Sleep disturbances appear to be even more common in patients with advanced cancer 
(Mercadante et al., 2017). Approximately half to three-quarters of outpatients attending 
cancer or palliative care clinics complain of some sleep disturbances (George et al., 2016; 
Yennurajalingam et al., 2015). These complaints were heterogeneous in nature and involved 
difficulties in falling asleep, trouble staying asleep, early morning awaking, or a complaint of 
nonrestorative sleep with a poor corresponding sleep efficiency (Savard & Morin, 2001). 
These complaints are all related to unsatisfactory sleep quantity and quality or insomnia. 
According to the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5), 
criteria for insomnia include a series of complaints of difficulty initiating/maintaining sleep, 
nonrestorative sleep for at least one month, and impairment of daily functioning (American 
Psychiatric Association, 2013). Sleep disturbance has been proven to be associated with poor 
clinical outcomes in terms of lower overall survival, more rapid disease progress, and poorer 
treatment response (Innominato et al, 2015). As a result, insomnia problems in patients with 
advanced cancer should not be neglected. 
 Patients with advanced cancer usually have numerous physical and psychosocial needs, 
including sleep problems. Unfortunately, oncologists and healthcare providers may pay too 
little attention or not have sufficient time to evaluate the cause for the sleep disturbance 
among patients with advanced cancer (Mercadante et al., 2017). Therefore, healthcare 
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providers need brief and robust instruments for assessing insomnia with sound psychometric 
properties. The Athens Insomnia Scale (AIS) and the Insomnia Severity Index (ISI) were 
developed according to standard diagnostic criteria for insomnia (Chiu et al., 2016). More 
specifically, the AIS uses the sleep difficulty described in the tenth International Statistical 
Classification of Diseases and Related Health Problems (ICD-10) (Soldatos et al., 2000). The 
ISI adopts the diagnostic criteria for insomnia outlined in the fourth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV), and the International Classification of 
Sleep Disorders (ICSD) (Bastien et al., 2001).  
 Moreover, the AIS contains two items assessing sleep duration and sleepiness which are 
not shared by the ISI. Additionally, the ISI emphasizes individuals’ worry about their sleep 
and noticeability of their sleep problems to others. Therefore, the AIS and ISI feature some 
dissimilarities in assessing insomnia. Nevertheless, both AIS and ISI have been found to be 
valid and reliable instruments for patients with cancer (Savard et al., 2005; Sun et al., 2011). 
Therefore, using either the AIS or ISI may assist healthcare providers to quickly assess 
insomnia for patients with advanced cancer. More importantly, among the well-established 
instruments on insomnia (e.g., the Sleep Condition Indicator) (Espie et al., 2014), the AIS and 
ISI are the most commonly used tools in both research and clinical practice.  
 However, it is unclear whether the two instruments (AIS and ISI) are equally good in 
assessing insomnia for patients with advanced cancer. Given that the AIS and ISI are both 
brief instruments (eight items in the AIS, and seven in the ISI) which increase the likelihood 
that all items will be completed, the major concern in defining whether the AIS and ISI are 
equally good is their psychometric properties (including factorial structure, reliability, and 
different types of validity). Unfortunately, psychometric properties of the AIS and ISI are 
lacking. To the best of the present authors’ knowledge, only two previous studies have 
simultaneously compared the psychometric properties of the AIS and ISI. One was on 
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adolescents (Chung et al., 2011), and the other was a meta-analysis (Chiu et al., 2016). 
Although both studies shared similar conclusions on the promising properties of both the AIS 
and ISI, their conclusions may not be generalized to patients with advanced cancer because 
most of the samples used in the psychometric testing were not patients with cancer. More 
specifically, in the meta-analysis (Chiu et al., 2016), there were only two studies separately 
assessing the psychometric properties of AIS and ISI: the AIS testing 195 patients with cancer 
(Sun et al., 2011) and the ISI testing 210 patients with cancer (Savard et al., 2005). As a result, 
the current literature lacks direct comparisons of the psychometric properties between the AIS 
and ISI among patients with advanced cancer. 
 Another consideration in the AIS and ISI is whether such subjective measures can 
accurately assess and quantify the insomnia. However, to the best of the present authors’ 
knowledge, most previous studies have used clinical insomnia diagnosis or subjective 
measures (e.g., self-reported depression) as the external criteria to examine the 
criterion-related validity for the AIS and ISI (Enomoto et al., 2018; Gómez-Benito et al., 
2011; Jeong et al., 2015; Morin et al., 2011). Therefore, empirical data on an objective sleep 
measure (i.e., actigraphy) is needed to verify the psychometric properties of such subjective 
measures (Lin et al., 2018).  
 The present study examined the psychometric properties of the AIS and ISI among 
Iranian patients with advanced cancer. More specifically, two different approaches in 
psychometric testing were applied (i.e., classical test theory and Rasch models in the modern 
test theory). Additionally, sensitivity and specificity of AIS and ISI were performed to obtain 
the optimal cutoff for indicating insomnia. Finally, a series of external criteria, including 
objectively measured sleep, were used to further understand AIS and ISI properties. It was 
anticipated that both the AIS and ISI would have satisfactory properties (including good 
internal consistency, acceptable test-retest reliability, verified unidimensional structures, and 
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supported measurement invariance or differential item functioning [DIF] across sex and 
insomnia condition) in both classical test theory and Rasch analyses. It was also expected that 
both the AIS and ISI would have good sensitivity and specificity to detect diagnosed 
insomnia. Finally, it was hypothesized that the AIS and ISI would have comparable 
associations with all the external criteria.  
Methods 
Participants and procedure 
 The present methodological study was conducted among eight oncology units of 
university hospitals in Tehran (n=5), Karaj (n=2), and Qazvin (n=1) from June 2015 to 
October 2018. Patients who met the following criteria were recruited using convenience 
sampling: (i) histologically verified malignant disease with cancer stage III or IV, (ii) were 18 
years of age or older, (iii) understood and communicated in the Persian language, and (iv) 
provided signed informed consent. Patients were excluded if they (i) were pregnant or 
lactating, (ii) had scheduled surgery within the next week, (iii) had cognitive problems as 
assessed by the Mini-Mental State Exam ( ≤ 23; Folstein et al., 1975), and (iv) had substance 
abuse problems. The study was approved by the ethics committee of the Qazvin University of 
Medical Sciences. All patients provided written informed consent.   
 Patients were recruited by three research nurses prior to their follow-up appointment. 
These nurses rated the level of functional impairment for each patient. The patients were 
trained to wear an Actigraph device in the hospitals (Ambulatory Monitoring, Inc. USA). 
Afterward, the patients wore the Actigraph on their wrists in two continuous weekdays of 
their own choice. Given that Iran has working days on Saturday and Sunday (resting days on 
Thursday and Friday), the participants selected two continuous days from Saturday to 
Wednesday.  
Measures 
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Clinical and demographic characteristics. Clinical information was collected from 
patient’s medical records. In addition, three trained psychiatrists, all were unaware of the 
patients’ insomnia conditions prior to the psychiatric interview, assessed the patients to 
determine whether the patients had insomnia. The interviews were held face-to-face in clinic 
rooms and the diagnosis was determined using the revised text DSM-IV. Interrater reliability 
scores between the psychiatrists were acceptable (intraclass correlation coefficient 
[ICC]=0.88) in pilot testing (n= 36). 
Athens Insomnia Scale (AIS). The AIS comprises eight items that assess the severity and 
effects of insomnia, and all items are rated using a 4-point Likert scale (0=no problem or 
equivalent meaning; 3=very severe problem or equivalent meaning). A total score is obtained 
after summing up all responses, and the total score ranges between 0 and 24, where the 
commonly accepted cutoff is 6 (Jeong et al., 2015). Additionally, a higher AIS score indicates 
a higher level of insomnia. The psychometric properties of the AIS have been supported in 
different language versions, including Spanish (α=0.86; test-retest reliability using ICC=0.75) 
(Gómez-Benito et al., 2011), Korean (α=0.88; test-retest reliability using ICC=0.94) (Jeong et 
al., 2015), and Chinese (α=0.83; test-retest reliability using Pearson correlation coefficient 
[r]=0.94) (Sun et al., 2011). However, to the best of our knowledge, there is no Persian 
version of the AIS. Thus, the authors used the standard translation procedure described below 
to translate the English AIS into Persian and ensure the linguistic validity.  
 The linguistic adaptation of AIS was performed through a standard procedure (Beaton et 
al., 2000) comprising several steps: (i) two bilingual translators who were native Persian 
speakers translated the English AIS into Persian independently. The translated versions were 
then synthesized into an interim Persian version via a discussion between both translators and 
a project manager. The interim Persian version was then translated back into English by two 
bilingual translators who were fluent in English. Also, the two back-translators were blinded 
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to the original English AIS. The back-translated English AIS was then assessed by an expert 
committee (comprising all translators, a methodologist, a health psychologist, a nurse, an 
oncologist, and a psychometrician). The committee evaluated the wordings and cultural 
equivalency of the back-translated English and original English AIS. The confirmed Persian 
AIS was then piloted on 35 patients with advanced cancer to ensure readability and cultural 
relevance. The final version of AIS was then administered to 573 patients with advanced 
cancer. 
Insomnia Severity Index (ISI). The ISI comprises seven items that assess the severity and 
effects of insomnia, and all items are rated using a five-point Likert scale (0=no problem; 
4=very severe problem). A total score is obtained after summing up all responses, and the 
total score ranges between 0 and 28, where 0-7 indicates absence of insomnia, 8-14 indicates 
sub-threshold insomnia, 15-21 indicates moderate insomnia, and 22-28 indicates severe 
insomnia (Morin et al., 2011). The ISI has been translated into Persian with good internal 
consistency (α=0.82 and 0.87), good test-retest reliability (ICC=0.84), and supported 
convergent validity (r=0.58 with Pittsburg Sleep Quality Index) (Yazdi et al., 2012).  
Edmonton Symptom Assessment Scale (ESAS). The ESAS comprises 10 items that assess 
the objective and subjective symptoms of patients with cancer across all stages. All items are 
rated on a 0-10 scale, where a higher score indicates a worse condition of symptoms. A total 
score is obtained after summing up all responses and the total score ranges between 0 and 100 
(Carvajal et al., 2011). The ESAS has been translated Persian with good internal consistency 
(α=0.88) and good test-retest reliability (r=0.86) (Khalili-Parapary et al., 2017). 
Hospital Anxiety and Depression Scale (HADS). The HADS comprises 14 items that assess 
two types of emotional distress: anxiety (seven items) and depression (seven items). All items 
are rated on a four-point Likert scale (from 0 to 3), where a higher score indicates the greater 
level of emotional distress. Two subscale scores are obtained after summing up related 
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responses (score ranges between 0 and 21 for each subscale) with each higher HADS 
subscale scores indicating higher level of anxiety or depression. The HADS has been 
translated Persian with good internal consistency (α=0.82 in the Anxiety subscale and 0.79 in 
the Depression subscale) (Lin & Pakpour, 2017). 
General Health Questionnaire-12 (GHQ-12). The GHQ-12 comprises 12 items that assess 
health, especially in psychiatric wellbeing. All items are rated on a four-point Likert scale 
(from 0 to 3), where a higher score indicates poor health. A total score is obtained after 
summing up all responses and the total score ranges between 0 and 36. The GHQ-12 has been 
translated into Persian with good internal consistency (α=0.87) and acceptable convergent 
validity (r=0.56 with quality of life measure) (Montazeri et al., 2003). 
Epworth Sleepiness Scale (ESS). The ESS comprises eight items that assess severity of 
daytime sleepiness. All items are rated on a four-point Likert scale (0=would never doze or 
sleep; 3=high chance of dozing or sleeping). A total score is obtained after summing up all 
responses and the total score ranges between 0 and 24, where a higher ESS score indicates 
greater sleepiness. The ESS has been translated into Persian with adequate internal 
consistency (α=0.79) and good test-retest reliability (ICC=0.84) (Imani et al., 2018). 
Pittsburgh Sleep Quality Index (PSQI). The PSQI comprises 19 self-rated items that assess 
sleep quality and disturbances. All items are rated on a four-point Likert scale (from 0 to 3), 
where a higher score indicated poor sleep quality. A total score is obtained after summing up 
all responses and the total score ranges between 0 and 57. The PSQI has been translated into 
Persian with adequate internal consistency (α=0.77) (Moghaddam et al., 2012). 
Actigraphy. Participants were invited to wear home-based wrist actigraphy (Ambulatory 
Monitoring, Inc. USA) to provide a measure of objective sleep (e.g., sleep and wake pattern; 
activity cycle). The sleep pattern was recorded in one-minute epochs and was digitized using 
the zero-crossing mode to a computer using Action-W software, version 2.6.9905. Following 
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this, sleep parameters were estimated using a Sadeh algorithm (Lin et al., 2018; Sadeh et al., 
1994). 
  
Statistical analysis 
 Participants’ characteristics, including demographics and clinical characteristics, were 
analyzed using mean and SD (for continuous variables) or frequency and percentage (for 
categorical variables). Regarding the psychometric properties using classical test theory on 
the AIS and ISI, McDonald’s ω was used to test the internal consistency (a value > 0.7 is 
preferred); corrected item-total correlation (a value > 0.4 is preferred), average variance 
extracted (a value > 0.5 is preferred), and composite reliably (a value > 0.6 is preferred) to 
assess the item coherence; and ICC to examine the test-retest reliability across two weeks (a 
value > 0.4 is preferred). Additionally, ceiling and floor effects for the AIS and ISI total 
scores were computed, where a value < 20% is desirable. Finally, two confirmatory factor 
analyses (CFAs) – assuming that the AIS and ISI have unidimensional structures (one CFA 
for AIS and another CFA for ISI) – were conducted to investigate the construct validity. The 
CFAs were performed using mean- and variance-adjusted weighted least squares (WLSMV) 
estimator. Comparative fit index (CFI) > 0.9, Tucker-Lewis index (TLI) > 0.9, root mean 
square error of approximation (RMSEA) < 0.08, and standardized root mean square residual 
(SRMR) < 0.08 were used to determine a supported CFA. 
 Regarding the psychometric properties using Rasch on AIS and ISI, the partial credit 
model was used. Additionally, a separation person and item reliability was adopted (a value > 
0.7 is preferred) to assess the reproducibility of respondents and items in responding AIS and 
ISI items , separation person and item index (a value > 2 is preferred) to examine how the 
respondents and items spread, infit mean square (MnSq) and outfit MnSq to investigate the 
item fit (a value between 0.5 and 1.5 is preferred), and differential item functioning (DIF) to 
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detect whether any AIS or ISI item has substantial DIF across sex or insomnia condition (a 
DIF contrast < 0.5 is preferred).  
 Apart from the formal psychometric testing mentioned above, a Receiver Operating 
Characteristic (ROC) curve and Youden’s index were used to examine the best cutoffs for 
AIS and ISI. Additionally, sensitivity and specificity were computed together with the area 
under curve (AUC), and an AUC > 0.7 was anticipated. After obtaining the cutoffs, 
McNemar’s test was used to understand whether the cutoffs are consistent with the 
psychiatric diagnosis and a nonsignificant p-value was expected. Afterward, several Pearson 
correlations were conducted to understand the associations between the AIS and ISI, and 
external criteria (anxiety, depression, function status, psychiatric wellbeing, daytime 
sleepiness, and sleep quality). Finally, different types of pain medications and Actigraph data 
were used to evaluate whether AIS and ISI cutoffs can effectively differentiate the insomnia 
severities among patients with advanced cancer. 
Results 
Participants’ characteristics 
 The 573 patients with advanced cancer had a mean age of 61.3 years (SD=10.7) years, 
and slightly more than half of them were males (n=326; 56.9%). Additionally, 304 of the 
participants had cancer stage IV (53.1%), and the remainder had stage III. The patients, on 
average, had received 8.7 years of education (SD=3.2), had Mini-Mental State Exam score of 
24.3 (SD=2.8), a Karnofsky Performance Scale Score at 51.8 (SD=11.6), and were 32.8 
months after diagnosis (SD=25.7). The highest three cancer diagnoses were gastrointestinal 
cancer (n=183; 31.9%), lung cancer (n=108; 18.8%), and breast cancer (n=91; 15.9%; Table 
1). Among the 573 participants, 458 agreed to wear the Actigraph and 25 had missing data in 
the Actigraph reports.  
(Insert Table 1 here) 
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Psychometric properties of the AIS 
 The AIS demonstrated promising psychometric properties (Table 2). At the item level, 
acceptances were high (88% to 100%); CFA-derived factor loadings were strong (0.61 to 
0.87); corrected item-total correlations were high (0.56 to 0.76); test-retest reliability was 
satisfactory (0.72 to 0.82); Rasch-derived infit (0.81 to 1.17) and outfit MnSq (0.79 to 1.14) 
fitted the underlying construct; and no substantial DIF was found across sex (DIF 
contrast=-0.43 to 0.43) or insomnia condition (DIF contrast=-0.23 to 0.19).  
 At the scale level using classical test theory (Table 3), the AIS had low ceiling (4.5%) 
and floor effects (3.9%); satisfactory internal consistency (ω=0.88); acceptable fitness, except 
for significant χ2 test, in the CFA (CFI=0.987, TLI=0.980, RMSEA=0.049, and 
SRMR=0.033); adequate average variance extracted (0.56) and high composite reliability 
(0.91); low standard error of measurement (2.57); and acceptable test-retest reliability 
(ICC=0.82). The Rasch analysis also supported the contention that the AIS has promising 
psychometric properties at scale level: separation reliability (0.88 and 0.84) and separation 
indices (2.75 and 2.30) were acceptable. 
(Insert Tables 2 and 3 here) 
Psychometric properties of the ISI 
  The ISI also demonstrated promising psychometric properties (Table 2). At the item 
level, acceptances were high (88% to 96%); CFA-derived factor loadings were strong (0.61 to 
0.81); corrected item-total correlations were high (0.43 to 0.67); test-retest reliability was 
satisfactory (0.72 to 0.82); Rasch-derived infit (0.72 to 1.14) and outfit MnSq (0.76 to 1.11) 
fitted the underlying construct; and no substantial DIF was found across sex (DIF 
contrast=-0.12 to 0.48) or insomnia condition (DIF contrast=-0.19 to 0.33).  
 At the scale level using classical test theory (Table 3), the AIS had low ceiling (7.4%) 
and floor effects (6.1%); satisfactory internal consistency (ω=0.79); acceptable fitness, 
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including nonsignificant χ2 test, in the CFA (CFI=0.995, TLI=0.990, RMSEA=0.029, and 
SRMR=0.023); adequate average variance extracted (0.54) and high composite reliability 
(0.89); low standard error of measurement (2.00); and acceptable test-retest reliability 
(ICC=0.79; Table 3). The Rasch analysis also supported the contention that the AIS has 
promising psychometric properties at scale level: separation reliability (0.98 and 0.78) and 
separation indices (7.20 and 2.71) were acceptable. 
Sensitivity and specificity values for AIS and ISI 
 The best cutoff score for AIS in distinguishing a patient with advanced cancer having 
insomnia was 7 with 86% sensitivity and 81% specificity. Also, the AUC for the AIS was 
0.86 (95% CI=0.82 to 0.90). The best cutoff score for ISI in distinguishing a patient with 
advanced cancer having insomnia was 9 with 86% sensitivity and 83% specificity. Also, the 
AUC for the ISI was 0.82 (95% CI=0.78 to 0.87; Table 4). Additionally, McNemar’s test 
showed that both the AIS and ISI cutoffs were consistent with psychiatric diagnosis (p=0.54 
for AIS and p=0.61 for ISI; Table 5). 
(Insert Tables 4 and 5 here) 
Relationships between AIS, ISI, and external criteria 
 AIS and ISI were mutually correlated (r=0.64). Additionally, the AIS and ISI shared 
similar magnitudes of correlations with all the external criteria: r=0.38 (AIS) and 0.41 (ISI) 
with ESAS score; 0.58 (AIS) and 0.53 (ISI) with the anxiety subscale from the HADS; 0.56 
(AIS) and 0.62 (ISI) with the depression subscale from the HADS; -0.50 (AIS) and -0.41 (ISI) 
with the Karnofsky Performance Scale Score; 0.61 (AIS) and 0.54 (ISI) with the GHQ-12 
score; 0.62 (AIS) and 0.64 (ISI) with the ESS score; and 0.55 (AIS) and 0.58 (ISI) with the 
PSQI score.  
Relationships between the AIS, ISI, types of pain medication, and objectively measured sleep 
 Analysis of variance showed that patients who took opioids had the highest AIS scores 
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(M±SD=9.48±3.57) and ISI scores (M±SD=10.33±4.61), followed by those taking 
non-opioid analgesics (M±SD=7.13±3.22 for AIS and 7.60±4.27 for ISI) and those taking 
other medications (M±SD=7.29±4.75 for AIS and 6.41±3.80 for ISI; F=7.28 [p<0.001] for 
AIS and F=13.45 for ISI [p<0.001]). Finally, Actigraph data (total sleep time, sleep efficiency, 
bedtime, wake time, sleep onset latency, and wake after sleep onset) were significantly 
different between insomniacs and non-insomniacs using the cutoffs found in the ROC 
findings (i.e., scoring 7 for the AIS and 9 for the ISI) (Table 6).  
(Insert Table 6 here) 
 
Discussion 
 To the best of the present authors’ knowledge, this is the first study to examine the 
psychometric properties of two commonly used instruments assessing insomnia (AIS and ISI) 
among patients with advanced cancer. Additionally, empirical evidence was provided to 
support the use of AIS and ISI for healthcare providers in caring for patients with an 
advanced cancer diagnosis. More specifically, the CFA and Rasch analysis findings supported 
the unidimensional structure for both the AIS and ISI. Previous studies have reported 
different factorial structures for AIS (one or two factors) (Enomoto et al., 2018; 
Gómez-Benito et al., 2011) and ISI (one to three factors) (Chung et al., 2011; 
Fernandez-Mendoza et al., 2012; Gerber et al., 2016) across different populations (e.g., 
adolescents and people with chronic pain). However, the different findings in the factorial 
structures could be contributing to the different sample characteristics. Indeed, psychometric 
properties of an instrument are usually sample-dependent and are likely to be varied in 
different populations (Lin et al., 2019). Given that the two previous studies comparing AIS 
and ISI properties did not examine the factorial structure (Savard et al., 2005; Sun et al., 
2011), future studies are therefore warranted in investigating the AIS and ISI structures in 
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patients with cancer to corroborate the findings presented here. Nevertheless, the 
unidimensional findings in the present study justify the use of cutoffs for both AIS and ISI. 
The item scores can be summed because all the items are embedded in the same construct 
(i.e., insomnia).  
 Although the present study’s results indicated that both the AIS and ISI shared robust 
and promising psychometric properties in the sample with advanced cancer, the AIS appeared 
to be slightly less inferior to the ISI regarding several psychometric characteristics. For 
example, the AIS as compared with the ISI had poorer CFA indices, higher standard error of 
measurement, and lower item separation reliability and index. One possible reason for this is 
that AIS includes some objective questions (e.g., sleep duration), which are likely to 
introduce bias due to recall error. On the other hand, the ISI emphasizes psychological 
aspects and may be biased by the recall error less than the AIS. Indeed, the present study also 
showed that the AIS had smaller effect sizes than the ISI in objectively measured data. The 
ISI also had its effect sizes of sleep efficacy and sleep onset latency that were twice the effect 
sizes of sleep efficacy and sleep onset latency in the AIS. 
 With the use of unidimensional AIS and ISI, healthcare providers can quickly assess 
insomnia among patients with advanced cancer. Healthcare providers may have some notion 
as to whether patients with advanced cancer have sleep disorders because insomnia is usually 
comorbid with other diagnostic issues. Use of these insomnia scales may also help healthcare 
providers to gain insight into the patients’ sleep problems, pain levels, and possible 
psychological health. Specifically, with the high accuracy (~90%) in classifying the diagnosis 
of insomnia, oncologists or related healthcare providers can use either AIS or ISI to quickly 
identify (or screen) whether an individual with advanced cancer has sleep problems. 
Additionally, as the present study’s results showed the relationships between AIS/ISI and 
other external criteria (e.g., pain and psychological health problems), healthcare providers 
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may use the AIS/ISI to further identify whether a detailed investigation on psychosocial 
health of the patient with advanced cancer is needed. Treatment directed to the causes for 
insomnia or the sleep problem per se could also more easily be initiated when the problem is 
detected.  
 Apart from the factorial structures, other psychometric findings in the present study 
were comparable with previous studies, especially the two studies on patients with cancer 
(Savard et al., 2005; Sun et al., 2011). More specifically, both Sun et al. (2011) and the 
present study found that the AIS had good internal consistency (α=0.83 vs. 0.871), good 
test-retest reliability (r=0.94 in a three-day interval vs. ICC=0.82 in a two-week interval), 
supported criterion-related validity, and satisfactory ROC findings (AUC=0.91 vs. 0.86). 
Moreover, both Savard et al. (2005) and the present study found that the ISI has acceptable 
internal consistency (α=0.90 vs. 0.776), good test-retest reliability (r=0.83 in a one-month 
interval vs. ICC=0.79 in a two-week interval), supported criterion-related validity, and 
satisfactory ROC findings (AUC=0.86 vs. 0.82). However, unlike prior research, which 
indicates a strong correlation between the ISI and PSQI (r=0.8) among a community sample 
of the general population (Morin et al., 2011), the present study found only moderate 
correlation between ISI and PSQI (r=0.58). A likely explanation for the different correlations 
is the different characteristics of the studied samples (elder people with advanced cancer [in 
this present study vs. middle-age adults in the general population [Morin et al., 2011]). 
Because people with cancer may have other reasons affecting their sleep quality (e.g., routine 
vital checks), the correlation between their insomnia and sleep quality may be lower. The 
aforementioned postulation is somewhat evidenced by the moderate correlation between the 
AIS and PSQI (r=0.55) in the present study. The study had several strengths. First, both AIS 
and ISI were tested using classical test theory and modern test theory (i.e., the Rasch models). 
Using different approaches to assess the psychometric properties of an instrument can 
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provide comprehensive information for potential users. Thus, different potential users can use 
the information if they are familiar or interested in such data. For example, use of classical 
test theory can ensure most healthcare providers are capable of interpreting the results 
because they are familiar with this method (Chang et al., 2015). On the other hand, the Rasch 
model conveys psychometric information with several well-known advantages, including the 
conversion from ordinal scale (e.g., Likert type scale) to an interval scale (i.e., using the unit 
of logit), reliability estimations separately for item and respondents, and measurement 
invariance (i.e., DIF) at the item level. Hence, DIF findings in the Rasch as compared with 
the measurement invariance findings from CFA are easier to identify which item is not 
invariant across subgroups.  
 The second strength of this study is that it used a series of external criteria to 
demonstrate the validity of AIS and ISI. Moreover, the external criteria included both 
subjective and objective measures. The use of objectively measured sleep is somewhat 
important because the use of actigraphy for assessing sleep outcomes has been well 
established and validated recently (Kapella et al., 2017; Weiss et al., 2010). Moreover, the 
major benefit of using actigraphy is to eliminate recall and social desirability biases. 
Although the AIS and ISI assess insomnia differently from actigraphy data (i.e., 
insomnia-related complains vs. activity level), the relationship between actigraphy data and 
the AIS/ISI cutoffs suggested some overlap. Future studies assessing insomnia among 
patients with cancer may adopt the proposed cutoffs presented here.  
 There are some limitations to the present study. First, all the patients with advanced 
cancer were recruited in Iran using a convenience sampling method. Although patients were 
recruited in different oncology units, the results are not necessarily generalizable to other 
ethnicities, other disease groups, or early stage of cancer, especially since different AIS and 
ISI structures have been reported across different populations in previous studies (Chung et 
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al., 2011; Enomoto et al., 2018; Fernandez-Mendoza et al., 2012; Gerber et al., 2016; 
Gómez-Benito et al., 2011). Second, the different early treatments may also contribute to 
different sleep performance among the patients with advanced cancer. However, the present 
study did not collect such information and cannot exclude such potential influences. Third, 
the cancer diagnoses varied among the participants (see Table 1) with some diagnoses having 
small sample sizes (e.g., 15 patients with skin cancer). Therefore, the findings might have 
little representativeness to some cancer types, including myeloma and skin cancer. Future 
studies using a large sample size for different cancer types are therefore needed.  
Fourth, those with cognitive problems were excluded from the study. Therefore, using AIS or 
ISI to assess insomnia for a specific proportion of patients with cancer might be questionable 
because cognitive impairment (e.g., chemo brain) is commonly observed among patients with 
cancer (Pendergrass et al., 2018).  
 Fifth, the present study did not control for a potential confounder (i.e., sleep-breathing 
disorders), which might have affected the CFA results for both the AIS and ISI. Future studies 
are therefore warranted in considering sleep-breathing disorders and to verify the CFA 
findings in the present study. Sixth, insomnia was diagnosed using the DSM-IV rather than 
the DSM-5 in this present study because the current psychiatric and medical practice in Iran 
is to use the DSM-IV (although the use of DSM-5 appears to be increasing among newer 
disorders that were not in DSM-IV such as internet gaming disorder [e.g., Wu et al., 2017]). 
Finally, the objective sleep measure using actigraphy may have limited validity because only 
two days for each participant was recorded. The recommendation of retrieving accurate sleep 
information using an actigraphy is 10 hours a day for at least four days (Lin et al., 2018). 
Unfortunately, the patients with advanced cancer in the present study found it difficult to 
tolerate wearing such a device for long periods. Therefore, this was an unavoidable limitation. 
Following the limitation of using actigraphy, the lack of using sleep diaries is another 
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potentially important limitation. Without sleep diaries, the collected data from actigraphy 
could not be supported. Therefore, the present study only used actigraphy to calculate the 
estimations of bedtime and waking time using the Sadeh algorithm (Sadeh et al., 1994). 
Conclusion 
 In conclusion, the AIS was translated into Persian and the study demonstrated that both 
Persian AIS and ISI have satisfactory psychometric properties among an advanced cancer 
sample in Iran. The unidimensional constructs of the AIS and ISI were supported by both 
CFA and Rasch models. Both AIS and ISI demonstrated promising concurrent validity as 
associations were found between the AIS, ISI, psychological factors, and cancer symptoms. 
Additionally, objective sleep measured using actigraphy was significantly related to the 
cutoffs of the AIS and ISI, where the cutoffs suggested by the ROC findings had strong 
sensitivity and specificity with satisfactory AUC. Consequently, the Persian AIS and ISI are 
appropriate instruments for healthcare providers to assess insomnia of patients with advanced 
cancer. 
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